Board of Directors
 | Audit Committee Charter (PDF) | | Compensation Committee Charter (PDF) | |
Nominating Committee Charter (PDF) | ||
|
|
|||||||
 = Committee Chair = Committee Member | Audit Committee | Compensation Committee | Nominating & Governance Committee |
|---|---|---|---|
| Ronald C. Renaud, Jr. President and Chief Executive Officer, Idenix Pharmaceuticals, Inc. |
|||
| Wayne T. Hockmeyer,
Ph.D. Chairman of the Board of Directors of MedImmune, Inc. |
| | |
| Thomas R. Hodgson* Former President and Chief Operating Officer of Abbott Laboratories | | | |
| Tamar Howson Partner JSB-Partners | | | |
| Robert Pelzer President and Chief Executive Officer Novartis Corporation | |||
| Denise Pollard-Knight,
Ph.D. Head of Phase4 Ventures |
| | |
| Anthony Rosenberg Global Head of Business Development and Licensing Novartis Pharma AG | < /tr> |
* Lead Director
Idenix has focused its efforts towards HCV due to the global unmet medical need for this viral disease. It is estimated that more than 170 million people worldwide are chronically infected with HCV.